Mortality in Autism
自闭症死亡率
基本信息
- 批准号:10732957
- 负责人:
- 金额:$ 43.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-19 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:8 year oldAccidental InjuryAdolescent and Young AdultAdultAgeAge Specific Death RateBehavior TherapyBiologyCaliforniaCause of DeathCessation of lifeCharacteristicsChildChild HealthClientClinicalComplexDataData FilesDeath RateDevelopmentDevelopmental DisabilitiesDiagnosisDrowningEligibility DeterminationEnrollmentEpidemiologyEpilepsyExcess MortalityFundingGenderGeneral PopulationHealthHealth InsuranceHealth PolicyHealth ServicesHispanicHousingIncomeIndividualInformation SystemsIntellectual functioning disabilityInterventionLife Cycle StagesLife ExpectancyLiteratureLongevityLow incomeMassachusettsMedicaidMedicaid eligibilityMonitorNatural HistoryNeurodevelopmental DisabilityOccupational TherapyPneumoniaPopulationPopulation StudyPrevalencePrognosisQualifyingReportingResearchRiskRisk FactorsSample SizeServicesSocial WorkSuicideSurveillance ProgramSwedenTimeTransportationUnited StatesUtahVocational EducationWisconsinadolescent with autism spectrum disorderagedautism spectrum disorderautistic childrenbeneficiarycohortcomorbiditycostdesigndisabilityeffective interventionepidemiology studyethnic disparityhealth care serviceimprovedindexingindividuals with autism spectrum disorderlongitudinal analysismental health counselingmortalitymortality disparitymortality riskprematureprogramspublic health insuranceracial disparityscreeningsexwaiveryoung adult
项目摘要
The long-term objective of the proposed project is to reduce excess mortality and improve life expectancy for
people with autism spectrum disorder (ASD). The specific aims are to: 1) determine age- and sex-specific
mortality risk in Medicaid beneficiaries with and without ASD; 2) examine cause-specific mortality risk in
Medicaid beneficiaries with and without ASD; 3) identify effect modifiers (e.g., gender and intellectual disability)
of mortality risk associated with ASD; and 4) assess racial and ethnic disparities in mortality risk in Medicaid
beneficiaries with and without ASD. In the United States, the reported prevalence of ASD among children aged
8 years has more than tripled over the past two decades, increasing from 6.7 per 1,000 in 2000 to 23.0 per
1000 in 2018. There were an estimated 6.9 million persons with ASD in the United States, including over 1.5
million children aged 3-17 years and 5.4 million adults aged 18-84 years. As a complex neurodevelopmental
disability, ASD often requires extensive lifetime health care and social services. Research on ASD has been
largely concentrated in understanding its biology, identifying risk factors, monitoring prevalence in children, and
evaluating treatments and interventions. Although substantially reduced life expectancy for individuals with
ASD has been speculated since the early 1990s, research on mortality and lifespan issues in autism remains
scant. Medicaid, including the Children’s Health Insurance Program, is the primary public insurance program
for individuals with ASD. The proposed project involves constructing a dynamic cohort of about 1 million
Medicaid beneficiaries with ASD and about 4 million Medicaid beneficiaries without ASD (two million matched
with the exposed cohort on state, year of enrollment, age at enrollment, and sex; and two million matched
additionally on type of eligibility) and analyzing longitudinal data over a 24-year study period (1999–2022).
Results from the proposed project will provide much-needed epidemiologic evidence for understanding the life-
course mortality risk, causes of death, effect modifiers of mortality risk, and racial and ethnic disparities in
mortality risk associated with ASD, and for developing effective interventions to reduce excess mortality and
informing health policy and service planning for people with ASD.
拟议项目的长期目标是降低过高的死亡率和提高预期寿命
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GUOHUA LI其他文献
GUOHUA LI的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GUOHUA LI', 18)}}的其他基金
Policy solutions for addressing structural racism in maternal health disparities
解决孕产妇健康差异中的结构性种族主义的政策解决方案
- 批准号:
10748871 - 财政年份:2023
- 资助金额:
$ 43.03万 - 项目类别:
Effectiveness of Mandatory Prescription Drug Monitoring
强制处方药监测的有效性
- 批准号:
8112992 - 财政年份:2011
- 资助金额:
$ 43.03万 - 项目类别:
Effectiveness of Mandatory Prescription Drug Monitoring
强制处方药监测的有效性
- 批准号:
8223182 - 财政年份:2011
- 资助金额:
$ 43.03万 - 项目类别:
相似海外基金
Comparison of cognitive-behavioural treatments for children with PTSD following an accidental injury: A multi-site RCT.
意外伤害后患有 PTSD 的儿童认知行为治疗的比较:多中心随机对照试验。
- 批准号:
nhmrc : 569660 - 财政年份:2009
- 资助金额:
$ 43.03万 - 项目类别:
NHMRC Project Grants
PSYCHOLOGICAL EFFECTS OF ACCIDENTAL INJURY IN CHILDREN
儿童意外伤害的心理影响
- 批准号:
6264550 - 财政年份:1998
- 资助金额:
$ 43.03万 - 项目类别:
PTSD AND SLEEP FOLLOWING SEVERE ACCIDENTAL INJURY
严重意外伤害后的创伤后应激障碍和睡眠
- 批准号:
2675324 - 财政年份:1996
- 资助金额:
$ 43.03万 - 项目类别:
PTSD AND SLEEP FOLLOWING SEVERE ACCIDENTAL INJURY
严重意外伤害后的创伤后应激障碍和睡眠
- 批准号:
2890673 - 财政年份:1996
- 资助金额:
$ 43.03万 - 项目类别: